Skip to content

Clinical application trial of noninvasive functional imaging for the assessment of patients with stable coronary artery disease using magnetocardiography

Clinical application trial of noninvasive functional imaging for the assessment of patients with stable coronary artery disease using magnetocardiography

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061289
Enrollment
Unknown
Registered
2022-06-19
Start date
2022-06-06
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

Gold Standard:D-SPECT diagnosis of myocardial ischemia
by&#32
MCG&#32
(MD-U41001,&#32
CSHMEDI&#32

Sponsors

Department of Cardiology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Outpatients with suspected stable coronary artery disease; 2. The age of the patient is greater than or equal to 18 years old; 3. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with confirmed coronary artery disease; 2. Patients with acute coronary syndrome; 3. Patients with acute myocardial infarction within three months; 4. Patients who have undergone PCI or CABG surgery; 5. Left ventricular ejection fraction < 50%; 6. Patients with severe heart valve disease; 7. Patients with obstructive or non-obstructive hypertrophic cardiomyopathy; 8. Patients with dilated cardiomyopathy; 9. Patients with severe arrhythmia (such as atrial fibrillation); 10. Patients with complex congenital heart disease; 11. Hypersensitivity to contrast medium and adenosine; 12. Metal implants that affect magnetocardiography examination; 13. The subject cannot cooperate to complete the magnetocardiogram examination; 14. Pregnant women; 15. Suffering from serious organ lesions or life expectancy less than 24 months.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Accuracy;Coronary flow reserve;Major adverse cardiovascular event;

Countries

China

Contacts

Public ContactYawei Xu

Department of Cardiology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine

xuyawei@tongji.edu.cn+86 18917683030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026